Literature DB >> 3133514

Intraoperative management of a dysfibrinogenemic patients with gastric cancer.

T Tsujinaka1, J Kambayashi, J Kang, M Sakon, T Mori.   

Abstract

The intraoperative management of a dysfibrinogenemic patient with gastric cancer is reported herein. In order to avoid abnormal bleeding, the fibrinogen level during a cancer-operation should be maintained above 60 mg/dl. Cryoprecipitate, however, is not suitable for fibrinogen supplementation because of its short life in vivo.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3133514     DOI: 10.1007/bf02470845

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  6 in total

1.  Fibrin generation during production of freeze dried antihaemophilic cryoprecipitate.

Authors:  O H Skjønsberg; P Kierulf; K Gravem; H Heistø; H C Godal
Journal:  Thromb Res       Date:  1986-02-01       Impact factor: 3.944

Review 2.  Congenital abnormalities of fibrinogen.

Authors:  E A Beck
Journal:  Clin Haematol       Date:  1979-02

3.  Congenital dysfibrinogenemia: fibrinogen Lille.

Authors:  M H Denninger; J S Finlayson; L A Reamer; A Parquet-Gernez; M Goudemand; D Menache
Journal:  Thromb Res       Date:  1978-09       Impact factor: 3.944

4.  Fibrinogen Philadelphia. A hereditary hypodysfibrinogenemia characterized by fibrinogen hypercatabolism.

Authors:  J Martinez; R R Holburn; S S Shapiro; A J Erslev
Journal:  J Clin Invest       Date:  1974-02       Impact factor: 14.808

5.  Metabolism and distribution of fibrinogen. I. Fibrinogen turnover in physiological conditions in humans.

Authors:  D Collen; G N Tytgat; H Claeys; R Piessens
Journal:  Br J Haematol       Date:  1972-06       Impact factor: 6.998

6.  Radioimmunoassay of human fibrinopeptide A.

Authors:  H L Nossel; L R Younger; G D Wilner; T Procupez; R E Canfield; V P Butler
Journal:  Proc Natl Acad Sci U S A       Date:  1971-10       Impact factor: 11.205

  6 in total
  1 in total

1.  Fibrinogen Osaka IV: a congenital dysfibrinogenemia found in a patient originally reported in relation to surgery, now defined to have an A alpha arginine-16 to histidine substitution.

Authors:  K Yamazumi; S Terukina; M Matsuda; J Kanbayashi; M Sakon; T Tsujinaka
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.